SEARCH

SEARCH BY CITATION

References

  • 1
    Gerweck LE ( 2000) The pH difference between tumor and normal tissue offers a tumor specific target for the treatment of cancer. Drug Resist Update 3: 4950.
  • 2
    Bevan AP, Drake PG, Bergeron JJ, Posner BI ( 1996) Intracellular signal transduction: the role of endosomes. Trends Endocrinol Metab 7: 1321.
  • 3
    Authier F, Posner BI, Bergeron JJ ( 1996) Endosomal proteolysis of internalized proteins. FEBS Lett 389: 5560.
  • 4
    Keeler C, Jablonski EM, Albert YB, Taylor BD, Myszka DG, Clevenger CV, Hodsdon ME ( 2007) The kinetics of binding human prolactin, but not growth hormone, to the prolactin receptor vary over a physiologic pH range. Biochemistry 46: 23982410.
  • 5
    Tettamanzi MC, Keeler C, Meshack S, Hodsdon ME ( 2008) Analysis of site-specific histidine protonation in human prolactin. Biochemistry 47: 86388647.
  • 6
    Horovitz A, Fersht AR ( 1990) Strategy for analysing the co-operativity of intramolecular interactions in peptides and proteins. J Mol Biol 214: 613617.
  • 7
    Loewenthal R, Sancho J, Fersht AR ( 1992) Histidine-aromatic interactions in barnase. Elevation of histidine pKa and contribution to protein stability. J Mol Biol 224: 759770.
  • 8
    Serrano L, Bycroft M, Fersht AR ( 1991) Aromatic-aromatic interactions and protein stability. Investigation by double-mutant cycles. J Mol Biol 218: 465475.
  • 9
    Ahmad S, Gromiha M, Fawareh H, Sarai A ( 2004) ASAView: database and tool for solvent accessibility representation in proteins. BMC Bioinformatics 5: 51.
  • 10
    Fraczkiewicz R, Braun W ( 1998) Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules. J Comput Chem 19: 319333.
  • 11
    Mancini AL, Higa RH, Oliveira A, Dominiquini F, Kuser PR, Yamagishi ME, Togawa RC, Neshich G ( 2004) STING Contacts: a web-based application for identification and analysis of amino acid contacts within protein structure and across protein interfaces. Bioinformatics 20: 21452147.
  • 12
    Jomain JB, Tallet E, Broutin I, Hoos S, van AJ, Ducruix A, Kelly PA, Kragelund BB, England P, Goffin V ( 2007) Structural and thermodynamic bases for the design of pure prolactin receptor antagonists: x-ray structure of Del1-9-G129R-hPRL. J Biol Chem 282: 3311833131.
  • 13
    Bolen DW, Rose GD ( 2008) Structure and energetics of the hydrogen-bonded backbone in protein folding. Annu Rev Biochem 77: 339362.
  • 14
    Street TO, Bolen DW, Rose GD ( 2006) A molecular mechanism for osmolyte-induced protein stability. Proc Natl Acad Sci USA 103: 1399714002.
  • 15
    Acevedo O, Guzman-Casado M, Garcia-Mira MM, Ibarra-Molero B, Sanchez-Ruiz JM ( 2002) pH corrections in chemical denaturant solutions. Anal Biochem 306: 158161.
  • 16
    Marti DN ( 2005) Apparent pKa shifts of titratable residues at high denaturant concentration and the impact on protein stability. Biophys Chem 118: 8892.
  • 17
    Giralt E, Viladrich R, Pedroso E ( 1983) Determination of acid dissociation-constants of histidine-containing peptides by proton magnetic-resonance spectroscopy. Org Magn Reson 21: 208213.
  • 18
    Tan YJ, Oliveberg M, Davis B, Fersht AR ( 1995) Perturbed pKa-values in the denatured states of proteins. J Mol Biol 254: 980992.
  • 19
    Oliveberg M, Arcus VL, Fersht AR ( 1995) pKa values of carboxyl groups in the native and denatured states of barnase: the pKa values of the denatured state are on average 0.4 units lower than those of model compounds. Biochemistry 34: 94249433.
  • 20
    Svensson LA, Bondensgaard K, Norskov-Lauritsen L, Christensen L, Becker P, Andersen MD, Maltesen MJ, Rand KD, Breinholt J ( 2008) Crystal structure of a prolactin receptor antagonist bound to the extracellular domain of the prolactin receptor. J Biol Chem 283: 1908519094.
  • 21
    Maciejewski PM, Peterson FC, Anderson PJ, Brooks CL ( 1995) Mutation of serine 90 to glutamic acid mimics phosphorylation of bovine prolactin. J Biol Chem 270: 2766127665.
  • 22
    Schenck EJ, Canfield JM, Brooks CL ( 2003) Functional relationship of serine 90 phosphorylation and the surrounding putative salt bridge in bovine prolactin. Mol Cell Endocrinol 204: 117125.
  • 23
    Piwnica D, Fernandez I, Binart N, Touraine P, Kelly PA, Goffin V ( 2006) A new mechanism for prolactin processing into 16K PRL by secreted cathepsin D. Mol Endocrinol 20: 32633278.
  • 24
    Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI ( 1993) The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133: 12921299.
  • 25
    Genty N, Paly J, Edery M, Kelly PA, Djiane J, Salesse R ( 1994) Endocytosis and degradation of prolactin and its receptor in Chinese hamster ovary cells stably transfected with prolactin receptor cDNA. Mol Cell Endocrinol 99: 221228.
  • 26
    Goffin V, Shiverick KT, Kelly PA, Martial JA ( 1996) Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. Endocr Rev 17: 385410.
  • 27
    Brooks DJ, Fresco JR, Lesk AM, Singh M ( 2002) Evolution of amino acid frequencies in proteins over deep time: inferred order of introduction of amino acids into the genetic code. Mol Biol Evol 19: 16451655.
  • 28
    Keeler C, Dannies PS, Hodsdon ME ( 2003) The tertiary structure and backbone dynamics of human prolactin. J Mol Biol 328: 11051121.